CLINICAL_TRIALS trial_result · 2009-11-17

Clinical Trial Update: Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) [Phase 3]

Phase 3 safety and efficacy study of Axid (nizatidine) in infants with gastroesophageal reflux disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Braintree Laboratories | Conditions: Gastroesophageal Reflux Disease, GERD | Phase 3 | Status: COMPLETED | Results posted: 2009-11-17